Eli Lilly delivered above-consensus results in the second quarter, surpassing Wall Street’s revenue and non-GAAP profit ...

Discover Marpai, Inc.'s Q2 2025 earnings insights, highlighting the transformative relaunch of MarpaiRx, cost reductions, and a roadmap to profitability ...

Over the past two years, our area has experienced "mass closures" of several pharmacy chains and independent stores, ...

Healthcare tech company GoodRx (NASDAQ:GDRX) missed Wall Street’s revenue expectations in Q2 CY2025 as sales only rose 1.2% ...

The PBM exam guidelines project: The NAIC already has a Market Regulation Handbook that helps states assess insurers and ...

A judge recently blocked an Arkansas law that would have banned PBMs from owning and operating pharmacies in the state.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $78.33, with a high estimate of $82.00 and a low estimate of $67.00. Marking an increase of 2 ...

Federal law bans state meddling in self-insured benefits. States want to curb pharmacy benefit managers. Regulators are ...

One week from now, national pharmacy benefit manager Express Scripts is expected to terminate its coverage with locally-owned ...

Sharon Faust, chief pharmacy officer at Navitus Health Solutions and PBMI Innovator Award winner, works to improve the pharmacy benefit system by promoting transparency, educating others about rules, ...

In his second video interview with Managed Healthcare Executive, PBMI Innovator Award winner David Blair discusses why breaking up traditional pharmacy benefit manager models is key to improving ...

Managing the cost of GLP-1 drugs for weight loss is the top priority in pharmacy benefits, says Mercer survey.